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Hematopoietic cells are attractive targets for gene therapy, but the conventional adenovirus (Ad) vectors, based on Ad5, transduce these cells
inefficiently. One reason for low permissiveness of hematopoietic cells to infection by species C Ads appears to be inefficient attachment. Vectors
pseudotyped with species B fibers are clearly more efficient at transducing hematopoietic cells than Ad5. To evaluate which Ad species B type(s)
would be themost efficient vector(s) for primary T-cells, B-cells andmonocytes, attachment to and entry of the species B1 serotypes 3p and 7p and the
species B2 serotypes 11p and 35 into primary PBMCs was studied. Ad11p and Ad35 were the only serotypes to show efficient binding and for which
uptake by PBMCs could be detected. Infection of PBMCs by Ad5, Ad11p and Ad35 was compared. Expression of Ad hexons was detected in
stimulated PBMCs, most frequently in T-cells, and in unstimulated monocytes, although B-cells appear to be refractory to productive infection.
Replication of Ad DNAwas severely restricted in most PBMCs. Neither hexon expression nor genome replication could be detected in unstimulated
lymphocytes, but FISH and a real-time PCR-based assay suggested that Ad11p and Ad35 DNA reach the nucleus. Activation thus appears to be
required for T-cells to be permissive to Ad gene expression. In summary, there are substantial differences between Ad3p and Ad7p on the one hand
and Ad11p and Ad35 on the other, in their ability to interact with PBMCs. Ad11p and Ad35 probably represent vectors of choice for these cell types.
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Adenoviruses (Ads) are nonenveloped, double-stranded
DNA viruses, commonly used as vectors in gene therapy. The
hematopoietic system is a particularly suitable target for gene
therapy since techniques for bone marrow and blood cell
transplantation are well established. Gene therapy applications
in hematopoietic cells have for example been aimed at the
correction of single gene disorders, suppression of HIV
replication, immunotherapy and improvements of transplanta-
tion and cancer therapies (Biagi et al., 2003; Kipps et al., 2000;
Miller et al., 2002; Rea et al., 1999, 2001; Van Tendeloo et al.,
2001). The conventional adenovirus vectors are based on Ad5.
It is however well documented that Ad5 (species C) have very
limited ability to infect or transfect cells of hematopoietic origin
(Andiman and Miller, 1982; Chen et al., 2002; Chu et al., 1992;⁎ Corresponding author. Fax: +46 90 129905.
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1988; Silver and Anderson, 1988).
Currently, there are 51 different human Ad serotypes (De
Jong et al., 1999), divided into six species, A to F (Wadell et al.,
1980), which differ in tissue tropism and patterns of disease
(Wadell, 1984, 2000). Many factors influence infectivity and
replication, but interaction of virions with specific host cell
receptors mediating attachment seems as a basic requirement for
efficient infection of host cells (Freimuth, 1996; Havenga et al.,
2002; Legrand et al., 1999; Leon et al., 1998; Rea et al., 2001;
Shayakhmetov et al., 2000; Von Seggern et al., 1999) and thus
represents one of the key determinants of cell and tissue tropism.
Our strategy to improve adenovirus-mediated gene therapy has
been to search for new vector candidates through identifying Ad
serotypes that show efficiency in attachment to target cells and
display tropism for the targeted cell types. In a previous study,
we demonstrated that Ad11p and Ad35 (species B2) efficiently
attached to various committed hematopoietic cell lines and
caused productive infections in some of these lines (Segerman et
97A. Segerman et al. / Virology 349 (2006) 96–111al., 2000). Ad35 fiber substituted vectors have been reported to
efficiently transfect cells of hematopoietic origin (Havenga et al.,
2002; Rea et al., 2001; Shayakhmetov et al., 2000), and also Ad3
fiber substituted vectors have been shown to transduce
hematopoietic cells with higher efficiency than Ad5 vectors
(Stevenson et al., 1997; Von Seggern et al., 2000). There are
obvious advantages of species-B-based Ad vectors in compar-
ison with the traditional species C vectors: (1) the low
seroprevalence (5–10% for Ad11 and Ad35 and ∼30% for
Ad7 as compared to 80% for Ad5) (Vogels et al., 2003), (2) the
ability to transduce non-coxsackievirus and adenovirus receptor
(CAR) expressing cells such as hematopoietic cells. In addition,
recent in vivo data from baboons indicate that the immediate
vector toxicity, related to triggering of innate immunity
responses, is much lower for vectors pseudotyped with an
Ad35 fiber as compared to traditional Ad5 vectors after
intravenous injection (Ni et al., 2005). Systemic inflammation
and cytokine release seem related to uptake into hepatocytes
(Shayakhmetov et al., 2004, 2005), and Ad35 psedotyped
vectors were not accumulated to the same extent in liver tissue
neither in mice (Shayakhmetov et al., 2004) nor in baboons (Ni
et al., 2005) and in summary showed a better safety profile.
CAR serves as attachment or fiber receptor for Ad2 and Ad5
(both species C) (Bergelson et al., 1997; Tomko et al., 1997).
The CAR protein is a component of tight junctions (in epithelial
linings) (Cohen et al., 2001; Walters et al., 2002) and is only
expressed to a limited extent on hematopoietic cells (Philipson
and Pettersson, 2004). Species BAds do not share fiber receptors
with species C Ads (Defer et al., 1990; Gall et al., 1996;
Stevenson et al., 1997), and we have in a previous report shown
that there are at least two different species B receptors (Segerman
et al., 2003a). Low cross-competition between species B
serotypes (regarding attachment) has been observed before
(Mei et al., 2002; Shayakhmetov et al., 2000), and our report
demonstrated that there are clear differences in receptor usage
between Ad3p and Ad7p vis-à-vis Ad11p and Ad35. CD46,
which belongs to the regulator of complement activation (RCA)
family of proteins and also has immunomodulatory functions
(Kemper et al., 2003; Marie et al., 2002), has been identified as
one of the species B fiber receptors (Gaggar et al., 2003;
Segerman et al., 2003b; Sirena et al., 2004). Several species B
Ads, but not Ad3 or Ad7, appear to efficiently bind to CD46
(Gaggar et al., 2003; Marttila et al., 2005; Segerman et al.,
2003b), although Ad3 has also been reported to use CD46 as a
cellular receptor (Sirena et al., 2004). Species B Ads form two
genetic clusters, B1 and B2 (Wadell et al., 1980), and Ad3p and
Ad7p (both species B1) not only differ in receptor usage but also
in tropism and disease pattern from the species B2 Ads: Ad11p,
Ad34 and Ad35. Most B1 Ads are mainly associated with acute
respiratory disease and unlike the species C Ads (e.g. Ad5) do
not establish persistence (Wadell, 1984, 2000). The B2 serotypes
11p, 34 and 35 have mainly been associated with persistent
infections of the kidney and possibly the urinary tract and can be
shed in urine for long periods (Wadell, 1984, 2000). Apart from
the other species B Ads, Ad3p and Ad7p also definitely belong
to some of the most commonly isolated Ad serotypes (Schmitz et
al., 1983).To evaluate which Ad species B type(s) would constitute the
most efficient vector(s) for primary T-cells, B-cells and
monocytes, attachment and entry of the species B1 serotypes
3p and 7p and the species B2 serotypes 11p and 35 into primary
PBMCs were studied. Ad early infection of PBMCs was further
characterized for Ad5, Ad11p and Ad35 since no entry into
PBMCs was detected for Ad3 and Ad7. Several groups have
reported high transduction efficiencies of species B2 pseudo-
typed vectors in hematopoietic cells, but interactions of the
unmodified virus with PBMCs have not been elucidated.
Results
Ad11p and Ad35 attach PBMCs with the highest efficiency
Viral infections start with attachment to cells, and to measure
Ad binding efficiencies to primary PBMCs, freshly isolated
(unstimulated) as well as culture stimulated cells were incubated
on ice with 35S-labeled virions of serotypes 3p, 5p, 7p, 11p or
35 (Fig. 1). Unspecific binding was determined with cold
competition, using an excess of the corresponding unlabeled
virions.
In contrast to the other virus types studied, Ad11p and Ad35
showed high binding efficiency to both unstimulated and
stimulated PBMCs. At the highest dose (10 pg/cell, i.e. 35,700
particles/cell), around 400 particles/cell of Ad11p or Ad35 were
bound to unstimulated T-cells and B-cells and 700 or 1000
particles/cell for Ad11p and Ad35, respectively, were bound to
unstimulated monocytes (Figs. 1a–c). After stimulation,
binding to T-cells increased almost 4-fold (to 1200 or 1800
particles/cell for Ad11p and Ad35, respectively) and binding to
B-cells increased approximately 2-fold (to 800 or 950 particles/
cell for Ad11p and Ad35, respectively). The binding to
monocytes increased 1.5-fold (to 900 or 1600 particles/cell
for Ad11p and Ad35, respectively) (Figs. 1a–c). Thus, Ad11p
and Ad35 showed the highest binding levels to stimulated T-
cells, among PBMCs. All serotypes bound to A549 cells, as
expected and at the highest applied viral dose, 1700 or 2200
particles/cell of Ad11p and Ad35, respectively, were bound to
A549 cells (Fig. 1d).
Ad5p and the species B1 serotypes 3p and 7p showed almost
no specific binding to PBMCs (Figs. 1a–c) but attached A549
cells very well (Fig. 1d), indicating that hematopoietic cells
show a very low expression of specific attachment receptors for
these serotypes which is well known to be the case regarding the
Ad5p receptor CAR (Philipson and Pettersson, 2004). At the
highest viral dose, ≤50 particles/cell were bound to unstimu-
lated T-cells, stimulated B-cells and stimulated monocytes, and
≤100 particles/cell were bound to stimulated T-cells, unstimu-
lated B-cells and unstimulated monocytes. Binding of Ad3p and
Ad7p was significantly higher than that of Ad5p only in the case
of unstimulated monocytes (Fig. 1c).
In conclusion, Ad11p and Ad35 were the only of the studied
species B serotypes that efficiently attached primary PBMCs,
and the binding levels of these serotypes to A549 cells were
only 1.2–1.4 times higher as compared to stimulated T-cells. In
agreement with earlier findings, Ad5p attached to PBMCs
Fig. 1. Binding of Ads to PBMCs and A549 cells. Unstimulated (open labels) and stimulated PBMCs (filled labels) as well as A549 cells were incubated with 1, 3 and
10 pg/cell of 35S-labeled Ad5p, Ad3p, Ad7p, Ad11p and Ad35, for 30 min at +4 °C. Unspecific binding was determined with cold competition and has been subtracted
from the data. The results are means (bound particles/cell) ± SEM of duplicate data from 2 to 3 independent experiments.
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most cell types.
Ad11p and Ad35 are internalized by PBMCs
To determine whether the Ad serotypes also internalized into
PBMCs, we next performed uptake assays as earlier described
(Shayakhmetov et al., 2003; Wickham et al., 1993). In short, to
measure uptake over time, both freshly isolated (unstimulated)
and culture stimulated cells were incubated with 35S-labeled
Ads (serotypes 3p, 5p, 7p, 11p or 35) for 0, 30, 60 and 120 min
at 37 °C. Thereafter, all cells were protease-treated to remove
cell-surface-associated particles, and protected counts were
determined as a measurement of internalized particles. To define
background levels, control cells were incubated with virions for
120 min on ice.
Protected counts could only be detected with assurance for
Ad11p and Ad35 (Fig. 2), and the experiment indicates uptake
of these serotypes in both unstimulated and stimulated PBMCs.
After 2 h of incubation, uptake (defined as protected particles
minus background on ice) in unstimulated T-cells was
approximately 100 (Ad11p) and 150 (Ad35) particles/cell, in
unstimulated B-cells 200 (Ad11p) and 360 (Ad35) particles/cell
and in unstimulated monocytes 270 (Ad11p) and 130 (Ad35)
particles/cell (Figs. 2a–c). In stimulated cells, the uptake after 2
h of incubation was approximately 490 (Ad11p) and 710
(Ad35) particles/cell for T-cells, 320 (Ad11p) and 330 (Ad35)
particles/cell for B-cells and 250 (Ad11p) and 820 (Ad35)particles/cell for monocytes (Figs. 2a–c). Thus, in T-cells, the
uptake increased 4.5- to 5-fold and in monocytes approximately
3.5-fold upon stimulation. In B-cells, no significant change in
uptake was detected after stimulation.
In A549 cells, after 2 h of incubation, the uptake was 520
particles/cell for Ad5p, 830 particles/cell for Ad3p, 930
particles/cell for Ad7p, 2300 particles/cell for Ad11p and 2900
particles/cell for Ad35 (Fig. 2d). Uptake in PBMCs was thus
markedly less efficient than in A549 cells and in agreement
with earlier findings (Colin et al., 2004) seemed most
inefficient in B-cells. In stimulated T-cells and monocytes,
the uptake seemed to reach a plateau and in all PBMCs uptake
followed a different kinetics than in A549 cells. The uptake of
Ad11p and Ad35 was 4–4.7 times higher in A549 cells than in
stimulated T-cells, even though the binding of these serotypes
to the two cell types was similar (1.2–1.4 times higher to
A549 cells).
Expression of Ad5p, Ad11p and Ad35 late proteins was
detected in stimulated PBMCs and unstimulated monocytes,
but viral genome replication was in general severely restricted
in PBMCs
Ad11p and Ad35 were the only Ad serotypes for which
internalization into PBMCs was detected. To evaluate whether
these serotypes productively infected PBMCs, we next
performed immunostainings for detection of hexons (the main
late protein) at 1, 48 and 96 h post infection (p.i.), with both
Fig. 2. Uptake of adenoviruses in PBMCs and A549 cells. Unstimulated (open labels) and stimulated (filled labels) PBMCs, as well as A549 cells, were incubated with
3 pg/cell of 35S-labeled Ad5p, Ad3p, Ad7p, Ad11p and Ad35 for 0, 30, 60 and 120 min at +37 °C. To determine background levels, control cells were incubated on ice
for 120 min with the same amount of virions (ice). At the end of the incubation period, all cells were treated with proteinase K to remove surface-bound virions, and
protected particles/cell were determined as a measurement of uptake of virions. The results are mean numbers ± SEM of duplicate data from 2 to 3 independent
experiments.
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studies of Ad interaction with PBMCs are based on Ad5 (or
Ad2) which is also the most commonly used Ad vector, we
included Ad5p as a reference.
Positive cells, indicating ongoing hexon production, were
seen to varying extents among stimulated PBMCs (Figs. 3a–c)
and unstimulated monocytes (Fig. 3d), but no unstimulated
peripheral blood lymphocytes (PBLs) expressing hexons could
be detected (data not shown). For unstimulated monocytes, a
very weak but over time increasing immunofluorescent signal
was seen in most cells for all Ad serotypes, indicating low
levels of hexon production (Fig. 3d). It is somewhat surprising
that Ad5p appeared to express similar levels of hexon protein
as Ad11p and Ad35 since uptake of Ad5p within the first 2
h p.i. was poor in all PBMCs (Fig. 2c). However, monocytes
are efficient phagocytosing cells, and uptake of Ad5p might
have occurred in the infection assays at later time points.
Regarding stimulated PBMCs, only in the case of stimulated
T-cells the positive cells constituted a substantial proportion of
the cell population, and a rough estimate is that 20–40% of the
cells were positive for Ad11p and Ad35 but only a few percent
were positive for Ad5p, at 48 h p.i. (Fig. 3a). Apart from the
situation in stimulated monocytes and B-cells, there was no
apparent difference in the number of infected cells or the
strength of the signal when comparing results at 48 h and 96h p.i. (data not shown), and thus the infection seemed less
delayed in stimulated T-cells than in the other two cell types.
In stimulated monocytes, 10–20 positive cells/slide for Ad11p
and Ad35 and 1–3 positive cells/slide for Ad5p were seen at
96 h p.i. The experiments were initiated with 100,000 cells/
slide, meaning that far less than 1% of the population seemed
to be productively infected. The immunofluorescent signal as
well as the number of positive cells increased between 48 and
96 h p.i. (Fig. 3c), and the highest immunofluorescent signals
of all cell types were seen in stimulated monocytes, indicating
the highest production of hexons/infected cell. Among
stimulated B-cells, only a few cells, infected with Ad11p or
Ad35, appeared to express the hexon protein at 48 and 96 h p.
i. As for stimulated monocytes, the immunofluorescent signal
of infected cells increased between 48 and 96 h p.i. (Fig. 3c).
No positive cells were found for Ad5p. Although the purity of
B-cells was very high, ranging from 95 to 99%, it should be
noted that the origin of the very few positive cells detected
could not be ascertained.
Ad late protein expression is preceded by viral DNA
replication. To detect signs of replication, we also quantified
the levels of viral DNA at 1, 24 and 48 h p.i., using real-time
PCR (Fig. 4). Stimulated monocytes were the only cell type for
which a significant increase in Ad DNA levels could be detected
(Fig. 4c). Between 24 and 48 h p.i. the total amount of Ad11p
100 A. Segerman et al. / Virology 349 (2006) 96–111and Ad35 DNA increased from 2.5 × 106 and 1.7 × 106 copies,
respectively, to 5.4 × 106 and 3.7 × 106 copies, respectively,
indicating that genome replication of these serotypes had
occurred (Fig. 4c). For Ad5p, no such increase was detected.
Fully permissive cells produce around 5 × 104–2 × 105 viral
particles/cell. We detected about 10–20 productively infected
stimulated monocytes/slide, suggesting a relatively high viral
genome replication/infected cell. In spite of the obvious late
gene expression seen in stimulated T-cells, Ad DNA replication
seemed severely restricted in these cells (Fig. 4a). The Ad11p
and Ad35 DNA levels decreased the first 24 h p.i. (as for
stimulated monocytes), and between 24 and 48 h p.i., there was
a tendency, although not significant, to an increase in the
number of genomes for all serotypes (Fig. 4a). The number of
dead cells was higher for stimulated cells, and stimulated T-cells
were especially prone to cell death. On average for T-cells, 20%
of the cells were dead for a given time point, and, due to cell
proliferation, the number of cells on average decreased by 15%
over the assay period. Thus, the maintenance of the Ad DNA
level between 24 and 48 h, despite reduced cell numbers,
suggests that some genome replication actually took place also
in stimulated T-cells. In unstimulated PBMCs and in stimulated
B-cells, the Ad DNA levels for all serotypes stayed more or less
constant over the 48 h assay period or in some cases became
slightly reduced and thus there was no indication of viral DNA
replication in these cell types (Figs. 4a–c). The mean number of
viral DNA copies/cell was in unstimulated T-cells: 5 copies/cell
for Ad5p, 60 copies/cell for Ad11p and 35 copies/cell for Ad35
(Fig. 4a).
In summary, neither replication of viral DNA (Fig. 4) nor
expression of the viral hexon protein (data not shown) could
be detected for any Ad serotype in unstimulated PBLs.
Whereas B-cells appeared generally nonpermissive to Ad
infections, T-cells seemed conditionally permissive and a
high proportion of stimulated T-cells supported Ad11p and
Ad35 late gene expression although viral genome replication
was very inefficient. Unstimulated monocytes did not
support detectable levels of genome replication, but the
majority of cells appeared to express low amounts of
hexons. Viral DNA replication was only clearly detectable in
stimulated monocytes (which also seemed to express the
highest amounts of hexons/infected cell), although a very
low proportion of stimulated monocytes seemed to support
Ad late gene expression. Unstimulated monocytes thus
seemed easily infected by Ads but less permissive to Ad
genome replication and late gene expression. However, in
stimulated monocytes, early infection seemed to be im-
paired, but these cells were highly permissive to Ad genome
replication and late gene expression.
Ad11p and Ad35 DNA could be detected also in the nuclei of
unstimulated lymphocytes
The preceding experiments indicated internalization of
Ad11p and Ad35 in unstimulated lymphocytes, although no
genome replication or expression of late proteins was
detected in these cells. To investigate whether Ad11p andAd35 were able to fulfil the first phase of the infectious cycle
and deliver their genome also to the nuclei of unstimulated
lymphocytes, FISH was performed at 1 h and 3 h p.i. and the
results were evaluated with a confocal microscope, making
possible the visualization of intracellular viral DNA (Figs. 5a
and b). Unstimulated lymphocytes are quiescent cells with a
minimal cytoplasm that forms a thin rim around the nucleus.
We used a protein reactive stain (Evans Blue) that visualizes
the cytoplasmic rim in red and leaves the less protein
containing nucleus as a big, mostly black dot in the middle
(Fig. 5).
Ad11p and Ad35 DNA were clearly detected in
association with the absolute majority of both T-cells and
B-cells, but Ad5p gave almost no signal in these cells
(Figs. 5a and b). In Ad5 infected A549 cells, the same Ad5
probe gave a strong signal (data not shown). At 1 h p.i.,
there was a strong signal in the periphery of the cells
which might partly correspond to cell-surface-associated
virions (Figs. 5a and b). Internalized viral DNA was mostly
found in large cytoplasmic/perinuclear grains and thus
appeared to reside in internalized vesicles of some kind,
but more diffusely distributed DNA (with a cloudy
appearance), localized more centrally in the cell, could also
be detected in some cells. At 3 h p.i., clouds of diffusely
distributed viral DNA, located more centrally within the
darker middle of the cells, were detected in the majority of
unstimulated lymphocytes, indicating that uncoating of
virions and import of DNA into the nucleus had taken
place (Figs. 5a and b).
Ad11p and Ad35 DNA accumulates in the nuclear fraction of
unstimulated T- and B-cells at 3 h postinfection
To follow the early kinetics of the Ad infection in
unstimulated PBMCs, viral DNA was quantified in the nuclear
and cytoplasmic fractions at different time points p.i. by real-
time PCR. Since the internalization procedure seemed ineffi-
cient in PBMCs (Fig. 2), all cells were protease-treated at 1 h p.
i. to avoid high background signals from non-internalized
particles.
Species B Ads (Ad7 and Ad35 pseudotyped vectors) have in
epithelial cell lines been reported to traffic into late endosomes/
lysosomes before acid-dependent escape into the cytosol, and,
as a consequence, the nuclear targeting of viral genomes occurs
at later time points p.i. than for species C Ads (Ad5) (Miyazawa
et al., 1999, 2001; Shayakhmetov et al., 2003). We took these
studies into account when deciding upon the time schedule.
However, unstimulated hematopoietic cells are almost devoid of
cytoplasm, and that might explain why the nuclear targeting of
viral genomes appeared to be 2–3 times faster in unstimulated
PBMCs as compared to in A549 and HeLa cells (Miyazawa et
al., 1999, 2001; Shayakhmetov et al., 2003). Initially, we
performed an experiment on unstimulated T-cells where we
adsorbed for only 30 min and quantified the amounts of viral
DNA at 30 min, 2 h and 6 h p.i. (Fig. 6a). At 30 min, almost all
viral DNAwas detected in the cytoplasmic fraction, but, after 2
h, most of the viral DNA had shifted to the nuclear fraction.
Fig. 3. Ad hexon expression in PBMCs. Stimulated T-cells (a), stimulated B-cells (b), stimulated monocytes (c) and unstimulated monocytes (d) were infected with 3
pg/cell of Ad5p, Ad11p and Ad35 and incubated with virions for 1, 48 and 96 h. The viral hexon protein (main capsid constituent) was visualized using a monoclonal
antibody (MAB8052; Labora Chemicon) directed against a conserved Ad epitope and an FITC-conjugated secondary antibody. Cell staining with Evans Blue (red
color) was used for visualization of the cells. In order to visualize the very weak signal in unstimulated monocytes (1 h–96 h), (d) the pictures only show the green
(viral) signal. Slides were evaluated using a standard fluorescence microscope, and representative pictures were taken at 160× magnification, using the same camera
settings for all pictures. NC = normal control cells for panels b, c and d are grouped together below panel d. (For interpretation of the references to colour in this figure
legend, the reader is referred to the web version of this article.)
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Fig. 3 (continued).
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Fig. 4. Replication of viral DNA in PBMCs. Unstimulated (open labels) and stimulated (filled labels) PBMCs (100,000 cells) were incubated with 1 pg/cell of Ad5,
Ad11p and Ad35 for 1, 24 and 48 h at 37 °C. At the end of the incubation, DNAwas purified from all samples and quantified using real-time PCR. The results are
means (Ad DNA copies) ± SEM of data from 3 to 6 independent experiments.
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internalization of virions resulted in very low amounts of viral
DNA copy numbers and uncertain data. Thus, we increased the
time for viral absorbation and also performed the experiment
incubating for 1 h, 3 h and 6 h.
For each cell type, at 1 h p.i., the levels of viral DNA in the
nuclear fractions and in the cytoplasmic fractions were roughly
equal (Figs. 6b–d and Table 1). After 3 h of incubation, most of
the viral DNA had accumulated in the nuclear fraction of
unstimulated T-cells (80%) and B-cells (70%) and at 6 h p.i. 80
and 90%, respectively, was present in the nuclear fraction for
these cell types (Figs. 6b and c; Table 1). For Ad35, there was a
shift towards the nuclear fraction between 1 h (50%) and 3
h (74%) in unstimulated monocytes, similar to the situation in T-
and B-cells (Fig. 6d and Table 1). However, 70% of the Ad11p
DNA was present in the nuclear fraction already at 1 h p.i. in
unstimulated monocytes, and no further shift towards the
nuclear fraction could be detected at later time points (Fig. 6 and
Table 1). In unstimulated monocytes, the total level of DNAwas
somewhat reduced over time, whereas in B-cells and T-cells, the
total amount of DNA remained approximately the same over
time (Fig. 6). The Ad5p DNA levels were very low; only a few
copies/cell could be detected in any of the cell types, and no
meaningful conclusions regarding distribution between cyto-
plasmic and nuclear fractions could be drawn (Fig. 6). The
highest amounts of viral DNAwere detected in monocytes andT-cells, and less than half of those amounts were present in B-
cells (Fig. 6 and Table 2). In Table 2, viral DNA copy number/
cell has been related to the number of internalized viral
particles/cell (Fig. 2), at 1 h p.i., (after subtraction of the
respective backgrounds), and, for Ad11p, there is a very good
agreement between the two measurements.
In summary, the amount of Ad11p and Ad35 viral DNA
detected in the nuclear fractions of unstimulated lympho-
cytes increased with time, and import of viral DNA to the
nucleus appears to mostly take place between 30 min and 3
h p.i., in agreement with the results in the FISH experiment
(Fig. 5).
Discussion
One important cause for the observed nonpermissiveness of
hematopoietic cells to species C Ads appears to be the low
capacity of species C Ads to attach to these cells (Chu et al.,
1992; Horvath and Weber, 1988; Silver and Anderson, 1988),
illustrated by the fact that ectopic CAR expression (Leon et
al., 1998) or exchange of the fiber (Havenga et al., 2002; Rea
et al., 2001; Shayakhmetov et al., 2000) has been sufficient to
render different hematopoietic cells susceptible to transfection
by Ad5-based vectors. Vectors pseudotyped with various
species B fibers clearly constitute more efficient vectors for
hematopoietic cells than Ad5 (Havenga et al., 2002; Rea et al.,
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study, Ad11p and Ad35 were the only serotypes that showed
efficient binding to PBMCs and the only serotypes for which
uptake into PBMCs could be detected. We conclude that these
serotypes would most probably constitute more efficient
vectors than Ad3 or Ad7 regarding transduction of T-cells,
B-cells or monocytes. Indication of Ad11p and Ad35 gene
expression was only evident in unstimulated monocytes and
stimulated PBMCs, but Ad11p and Ad35 viral DNA was
detected within the majority of unstimulated lymphocytes andFig. 5. Detection of Ad DNA in unstimulated lymphocytes using FISH. Unstimulated
and incubated with virions for 1 and 3 h. After hybridization with random DIG-labeled
Ad35), viral DNA was visualized using peroxidase-conjugated α-DIG antibodies a
visualize the cell morphology. Slides were evaluated using a Leica confocal microsco
500× magnification, are shown. The indicated squares in blue are magnified ×4. NC
diffusely distributed (3 h p.i.).80% of the internalized viral DNA was found nuclear-
associated at 3 h p.i. in the same cells. Thus, our results
indicate that the first step towards gene expression, transduc-
tion, would be very efficient using either an Ad11p- or Ad35-
based (or pseudo-typed) vector and will not depend on prior
activation of PBMCs. Ad35 showed somewhat higher binding
to PBMCs than Ad11p, but in the quantifications of
internalized and cell-associated viral DNA, Ad11p generally
showed higher scores. The main conclusion must be that they
seem to interact with PBMCs with similar efficiencies, and itT-cells (a) and B-cells (b) were infected with 1 pg/cell of Ad5p, Ad11p or Ad35
Ad5 probes (for detection of Ad5) or Ad11p probes (for detection of Ad11p and
nd an FITC substrate. A protein reactive stain, Evans Blue (red), was used to
pe system, and representative pictures from the mid-section of the cells, taken at
= normal control cells. The arrows indicate viral DNA in grains (1 h p.i.) and
Fig. 5 (continued ).
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them should be given preference.
Our study thus reveals that there are substantial differences
in the ability of the species B Ads 3p and 7p contra 11p and
35 to attach to primary PBMCs, probably reflecting the earlier
identified differences in receptor usage between these
serotypes. Our characterization of receptors showed that
Ad3p, Ad7p and Ad11p shared one receptor and that Ad11p
in addition used another receptor that was also used by Ad35
but not by Ad3 or Ad7p (Segerman et al., 2003a). Earlier
cross-competition data also suggest that Ad3 and Ad35
mostly use separate receptors (Shayakhmetov et al., 2000).
CD46 which functions as a receptor for Ad11p (Segerman et
al., 2003b) and Ad35 (Gaggar et al., 2003) is expressed on all
nucleated cells (Johnstone et al., 1993) and possibly mediated
binding of Ad11p and Ad35 to PBMCs. However, in spite
that Ad3 has been reported to use CD46 as a receptor, (Sirena
et al., 2004) our present findings rather support the conclusion
that CD46 is not a receptor of importance for either Ad3p or
Ad7p (since these serotypes showed the same low binding
efficiency as Ad5 to most PBMCs) (Gaggar et al., 2003;
Marttila et al., 2005; Segerman, 2004; Segerman et al.,2003b). Recently, CD80 (B7-1) and CD86 (B7-2) have also
been suggested to function as cellular attachment receptors for
Ad3 (Short et al., 2004). Both CD80 and CD86 are mainly
expressed on antigen-presenting cells (dendritic cells, mono-
cytes and macrophages). Our results showed a somewhat
higher binding of both Ad3 and Ad7 to unstimulated
monocytes, which have been reported to express high levels
of CD86, than to the other cell types. However, also Ad3p
and Ad7p binding to unstimulated monocytes was inefficient.
Consequently, the main receptor for Ad3 and Ad7, expressed
on permissive cells such as A549 or HeLa cells, remains to be
identified and do not appear to be present on PBMCs.
However, Ad3p and Ad7p have been shown to efficiently
attach CD34 positive hematopoietic stem cells (Mei et al.,
2004) and K562 cells (Sirena et al., 2004). Summoning
previous findings with our present results, there appear to be
pronounced differences in the distribution of the two species
B receptors on hematopoietic cells which could be useful
regarding choice of vector candidate.
Both species B2 and C Ads cause persistent infections
(Adrian et al., 1988; Allard et al., 1992; de Jong et al., 1983;
Fox et al., 1969, 1977). Early studies have suggested that
Fig. 6. Ad DNA in nuclear and cytoplasmic fractions of PBMCs early after infection. Unstimulated PBMCs were incubated with 3 pg/cell of Ad serotypes 5p,
11p or 35 for 30 min (a) or 1 h at 37 °C (b–d). Thereafter, the cells were protease-treated and harvested or incubated further for 1.5 and 5 h (a) or 2 and 5 h (b)
at 37 °C. Nuclear (filled labels) and cytoplasmic (open labels) fractions were separated at the end of the incubation, and viral DNA was quantified in all fractions
by real-time PCR. The control was kept on ice for 2 h (a) or 3 h (b–d). The results are means (DNA copies/cell) ± SEM of data from 3 to 6 independent
experiments.
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1958; Israel, 1962; van der Veen and Lambriex, 1973), and
recent findings indicate that T-cells and possibly some non-
lymphoid cell types function as sites for persistence of species
C Ads (Garnett et al., 2002). Sites of persistence for species B2
Ads remain uncharacterized. In vitro, it has been repeatedly
demonstrated that various hematopoietic cells might harbor
persistent Ad species C infections (Andiman and Miller, 1982;
Chu et al., 1992; Faucon et al., 1982; Flomenberg et al., 1996;
Silver and Anderson, 1988), and no hematopoietic cell so far
investigated seems fully permissive to Ad lytic infection
(Segerman et al., 2000). Freshly isolated peripheral blood
lymphocytes (PBLs) have been observed to be highly resistant
to Ad species C productive infections (Horvath and Weber,
1988; Lambriex and Van der Veen, 1976; Silver and Anderson,
1988), and this nonpermissiveness of PBLs can only be
slightly lifted after phytohemaglutinin stimulation (HorvathTable 1
The mean proportion (%) ± SEM of viral DNA detected in the nuclear fractions of
Ad11p
1 h 3 h
T-cells, unstimulated 57 ± 0.5 81 ± 1.5
B-cells, unstimulated 58 ± 6 68 ± 9
Monocytes, unstimulated 76 ± 1.5 74 ± 2and Weber, 1988; Lambriex and Van der Veen, 1976). Our Ad5
late gene expression and genome replication data are in line
with these earlier observations and in addition show that
freshly isolated PBLs are also nonpermissive to Ad species B2
productive infections. However, species B2, in contrast to
species C, Ad late gene expression was detected in a high
proportion of stimulated T-cells. The more efficient attachment
and entry of these Ads into PBMCs probably resulted in a
higher frequency of infected cells. B-cells appeared generally
nonpermissive to Ad growth, but, since Ad11p and Ad35
efficiently entered and were found nuclear-associated in
unstimulated PBLs, our data indicate that variations in
permissiveness to Ad gene expression rather than Ad entry
resulted in the great variations in hexon expression detected in
PBLs. In addition, Ad DNA replication seemed greatly
impaired in PBLs as well as in unstimulated monocytes in
spite of the relatively frequent and strong signal of hexonPBMCs at 1, 3 and 6 h postinfection
Ad35
6 h 1 h 3 h 6 h
80 ± 3.5 53 ± 6 79 ± 2 81 ± 4
87 ± 3 55 ± 3.5 76 ± 4.5 87 ± 3.5
76 ± 4 50 ± 13 74 ± 4 77 ± 0.5
Table 2
Internalized viral DNA copies/cell compared to internalized viral particles/cell at
1 h postinfection, presented as mean numbers ± SEM (viral dose = 3 pg/
cell = 10,700 particles/cell)
DNA Particles
Ad11p Ad35 Ad11p Ad35
T-cells, unstimulated 153 ± 26 118 ± 20 132 ± 25 149 ± 15
B-cells, unstimulated 70 ± 20 53 ± 7 61 ± 34 131 ± 23
Monocytes, unstimulated 240 ± 46 170 ± 22 251 ± 55 99 ± 73
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suggest that E1A expression is suppressed and sometimes
blocked in lymphocytes (Lavery and Chen-Kiang, 1990;
McNees et al., 2004; Silver and Anderson, 1988; Tang et al.,
1997). A recent study has shown that certain T-cell lines failed
to support Ad5 gene expression, despite that efficient entry was
achieved after CAR transduction of these cell lines, and the
E1A (like the CMV) promoter seemed inactive in the same T-
cell lines (McNees et al., 2004). Although only a few
stimulated monocytes seemed to become Ad-infected and the
infection was clearly delayed, both DNA replication and gene
expression seemed most unimpaired in these cells as compared
to the other PBMC cell types. Taken together, among PBMCs,
monocytes and T-cells support Ad late gene expression and to
some extent Ad genome replication and might constitute
putative sites for persistent replication of species B2 Ads, in
line with earlier findings regarding sites of persistence for
species C Ads (Garnett et al., 2002).
The species C Ad persistent infection is characterized by
intermittent fecal shedding of virions for months and even years
(Adrian et al., 1988; Allard et al., 1992; Fox et al., 1977).
Species C Ad DNA has been detected in mucosal lymphocytes
or T-cells in the absence of infectious virus (Evans, 1958;
Garnett et al., 2002; Neumann et al., 1987), and PHA
stimulation of tonsillar lymphocytes has been shown to increase
the recovery of infectious species C Ads and enhance viral
replication in such cells (Lambriex and Van der Veen, 1976; van
der Veen and Lambriex, 1973). Our finding that T-cells vary in
permissiveness to Ad late gene expression dependent of T-cell
activation might explain the observed intermittent cycles of Ad
excretion. The presence of NF-κB binding sites, upstream of the
E3 promoter in the Ad5, Ad11p and Ad35 genomes (Basler et
al., 1996; Deryckere and Burgert, 1996; Williams et al., 1990),
also suggests that these Ads have evolved to respond to T-cell
stimulation signals and the Ad5 E3 promoter has indeed been
reported to be extremely sensitive to T-cell stimulation signals
in latently infected T-cells (Mahr et al., 2003). Our data
strengthen the hypothesis that T-cells might function as a
reservoir of species C Ads (Garnett et al., 2002; Mahr et al.,
2003; McNees et al., 2004) and include species B2 Ads as
potential users of T-cells for persistence.
In summary, our study has revealed major differences of the
species B1 Ad serotypes 3p and 7p vis-à-vis the species B2
serotypes Ad11p and Ad35 in their ability to interact with
primary lymphocytes and monocytes, confirming previous
results regarding differences in receptor usage (Gaggar et al.,
2003; Segerman et al., 2003a, 2003b; Shayakhmetov et al.,2000). Further studies are required to clarify the impact of
receptor usage on tropism and disease pattern. However, it is
probably not a coincidence that species B2 Ads that have
mainly been associated with persistent infections at the same
time are most efficient among human Ads in binding and
infecting hematopoietic cells (Havenga et al., 2001; Mei et al.,
2004; Rea et al., 2001; Segerman et al., 2000; Shayakhmetov et
al., 2000).
Materials and methods
Purification of PBMCs from buffy coats
T-cells, B-cells andmonocytes were purified from buffy coats
obtained from the unit for transfusion medicine at the University
Hospital of Northern Sweden (NUS). The buffy coats were
diluted 1:3 in PBS and then separated by density centrifugation
using Lymphoprep (density = 1.077) (Nycomed) for 20 min at
800 × g and room temperature (RT). The mononuclear cell band
was recovered, and the cells were washed twice, once in Tris–
Hank's (a 1:1 mixture of Hank's balanced salt solution (Sigma)
and Tris buffer containing 22 mM Tris base and 128 mM Tris–
HCl, pH 7.2, with 0.2% human serum albumin (HSA;
Pharmacia) and once in red blood cell lysis buffer (154 mM
NH4Cl, 10 mMKHCO3, 0.1 mM EDTA, pH 7.3) and pelleted at
low speed centrifugation to remove platelets. The cells were then
cultured at 37 °C for 1 h in RPMI 1640 (Gibco) supplemented
with 20 mM HEPES, 20 U of penicillin G and 20 μg
streptomycin per ml (PEST) (Gibco) and 20% normal human
serum (HNS) fromABRhD+ donors. B-cells were purified from
the non-adherent cells using the positive selection kit,
Dynabeads M-450 CD19 and DETACHaBEAD CD19 (Dynal,
Oslo, Norway), according to the instructions of the manufac-
turer. Monocytes were purified from the adherent cell population
using a Monocyte Negative Isolation kit (Dynal) according to
the instructions of the manufacturer (after loosening the adherent
cells on ice using ice-cold Tris–Hank's and a cell scraper).
Briefly, the kit is based on antibodies directed against cell
surface markers of different contaminating cells, e.g. granulo-
cytes. T-cells were isolated using a T-cell negative isolation kit
(Dynal) according to the instructions of the manufacturer, which
removes for example NK-cells. To examine the purity of the
recovered PBMCs, B-cells were probed for CD19 expression, T-
cells for CD3 expression and monocytes for expression of
CD14, using R-phycoerythrin (RPE)-labeled monoclonal anti-
bodies (DakoCytomation, Glostrup, Denmark) and FACScan.
The PBMCs were always ≥90% pure, and, typically, B-cells
were 98% CD19+, T-cells 95% CD3+ and N90% of the
monocytes were CD14+.
Binding and uptake experiments on unstimulated cells
were performed on freshly isolated PBMCs, and infection
assays on unstimulated cells were performed on purified
PBMCs kept at +4 °C overnight in RPMI 1640 with 0.4%
HSA, at a concentration of 4 × 106 cells/ml. The cell viability
for unstimulated PBMCs was very good (N90%), and the
number of cells was more or less constant over the assay
periods.
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Purified PBMCs were seeded at a cell concentration of
1 × 106 cells/ml and cultured in RPMI 1640 supplemented with
20 mM HEPES, 1 × PEST, 10% fetal bovine serum (FBS;
Gibco) and stimulation factors for T-cells, B-cells and
monocytes, respectively. For stimulation of T-cells, phytohe-
magglutinin (PHA) at 1 μg/ml and phorbol myristate ester
(PMA) at 30 nM (both from ICN, Irvine, USA) were added to
the medium. For stimulation of monocytes, M-CSF (Labora
Chemicon, Sollentuna, Sweden) at 20 ng/ml and GM-CSF at 5
ng/ml (Labora Chemicon) were used. Finally, for stimulation of
B-cells, pokeweed at 0.5 μg/ml (ICN) and IL-4 at 10 ng/ml
(Labora Chemicon) were added to the medium. The concentra-
tions of stimulation factors used were according to the
recommendations of the manufacturers. The cells were
stimulated in culture for 5 days before experiments were
performed. After 1 day of stimulation, colonies could be seen,
and, after stimulation for 5 days, the size of the majority of the
cells had increased. After 5 days of stimulation, a marked
induction of IL-2 receptors (CD25) was also detected on T-cells,
and, typically, around 80% of the T-cell population were
positive for CD25 expression (data not shown).
Adenoviruses
The adenovirus types used in this study, 3p (GB), 5p (Ad75),
7p (Gomen), 11p (Slobitski) and 35 (S-761), were all typed with
respect to their DNA restriction patterns (Adrian et al., 1986).
All of these types were grown in A549 cells and purified in CsCl
gradients as described earlier (Mei et al., 1998). The concentra-
tion of virions was determined by spectrophotometry at 260 and
330 nm according to the following formula. One unit of optical
density or Adsorbance (A) at 260 nm (A260) – A330 corresponds
to 1012 particles/ml which corresponds to 280 μg/ml of virions.
Binding experiments using 35S-labeled adenovirus particles
35S-labeling of Ads was performed as previously described
(Segerman et al., 2003a). Binding experiments were
performed on unstimulated freshly isolated PBMCs and on
culture stimulated PBMCs in 96-well microtiter plates using
75,000–100,000 cells/well, in an interaction volume of 75 or
100 μl of PBS–1% HSA–0.01% NaN3 buffer (binding
buffer), respectively. 1, 3 and 10 pg/cell (corresponding to
ca. 3600, 10,700 and 35,700 particles/cell) of 35S-labeled
Ad3p, Ad5p, Ad7p, Ad11p and Ad35 were added to the cells.
To allow binding of the viruses, the cells were incubated with
the virions for 30 min (min) at +4 °C on a rocker platform.
Thereafter, the cells were washed once with 150 μl binding
buffer and then resuspended in 100 μl of the same buffer and
transferred to scintillation vials. Two milliliters of scintillation
liquid, Optiphase Hi Safe 3 (Wallac), was added, and counts
per minute (CPM) were measured in a liquid scintillation
counter (Wallac, 1409).
Unspecific binding to each cell type and for each virus type
was determined by binding in the presence of a 20–100 timesexcess of unlabeled viral particles of the corresponding type.
The unspecific binding varied between 0.07% and 0.3% of
added virions, depending on the cell type and virus type.
Uptake experiments using 35S-labeled adenovirus particles
Uptake experiments were done on unstimulated freshly
isolated PBMCs and also on PBMCs that had been stimulated in
culture as described above. The uptake experiments were
performed in 96-well microtiter plates using 75,000–100,000
cells/well in an interaction volume of 75 or 100 μl, respectively,
of PBS–1% HSA buffer (uptake buffer). The cells were
incubated with 3 pg/cell of 35S-labeled Ad3p, Ad5p, Ad7p,
Ad11p or Ad35 for 0, 30, 60 or 120 min at 37 °C. In a control
plate, cells were incubated with the same amount of virus for
120 min on ice. At the end of the incubation period, all cells
were washed in 150 μl uptake buffer and incubated in 75 or 100
μl, 200 μg/ml proteinase K (Amersham Biosciences) containing
PBS–0.2% HSA buffer for 60 min on ice. Thereafter, 100 μl
Pefabloc C (Roche, Basel, Switzerland) was added to a final
concentration of 2 mM. The cells were pelleted and washed in
an additional 150 μl uptake buffer containing 2 mM Pefabloc C
and thereafter transferred to scintillation counter vials and
CPMs were measured as described above.
Infection assays
50,000 cells (in 50 μl) or 100,000 cells (in 100 μl) were
infected with 1 or 3 pg/cell adenovirus in a microtiter plate or in
Eppendorf tubes. The viruses were allowed to adsorb to the cells
in RPMI 1640 containing 0.2% HSA for 1 h (h) at 37 °C on a
rocker platform. Thereafter, the cells were pelleted and washed
in 150 μl PBS–0.2% HSA buffer before preparation for analysis
or before continued incubation in 50 μl or 100 μl RPMI 1640
culture medium (containing FBS and stimulation factors in
experiments on stimulated cells or HNS in experiments on
unstimulated cells) in a microtiter plate or a sterilized microtiter
plate for incubations exceeding 6 h.
Real-time PCR-based assays
To measure replication of Ad DNA, 1 × 105 cells were
infected with 1 pg/cell of Ad5, Ad11p or Ad35 and incubated
for 1, 24 or 48 h. The samples were thereafter saved at −20° for
subsequent DNA preparation and real-time PCR analysis.
To measure import of Ad DNA into the nuclei of cells,
1 × 105 cells were infected with 3 pg/cell of Ad5, Ad11p or
Ad35 and incubated for 1, 3 or 6 h. After adsorbation of the
viruses, the cells were pelleted and treated with 200 μg/cell
proteinase K (Amersham Biosciences) for 60 min on ice.
The protease treatment was interrupted by adding 2 mM
Pefabloc C (Roche). The cells were washed in 150 μl PBS–
0.2% HSA buffer before continued incubation or preparation
of nuclei using 200 μl NP-40 lysis buffer (containing 10 mM
Tris, pH 7.4, 10 mM NaCl, 3 mM MgCl2 and 2% Nonidet
P-40 (NP-40)). The cells were incubated on ice for 15 min in
NP-40 lysis buffer. Thereafter, the nuclei were pelleted at
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at −20 °C for subsequent DNA preparation and real-time
PCR analysis.
The design of Ad primers and probes has recently been
described, together with the entire procedure for the
quantitative PCR analysis of Ads (Allard et al., 2001;
Hernroth et al., 2002). Briefly, a pair of degenerated primers
selected from the conserved region of the Ad hexon gene was
used. Two different probes, Ad:ACDEF and Ad:B, were needed
to ensure optimal amplification and quantitation of both species
C and species B Ads. The probes were labeled with the
fluorophores 6-carboxy-fluorescein (FAM) and 6-carboxy-
tetramethyl-rhodamine (TAMRA). The amplification was
performed in a 25-μl reaction mixture with a PCR core reagent
(Applied Biosystems, Foster City, USA). The reaction mixture
contained 10 μl titrated standard DNA or 10 μl Ad5, Ad11 or
Ad35 DNA (purified using the QIAAmp Blood Mini kit
(Qiagen) according to the manufacturer's protocol), 1 × Taqman
core buffer, 5 mM MgCl2, dATP, dCTP and dGTP at 200 μM
each, 400 μMdUTP, each primer at 900 nM, 225 nM probe, 0.25
U AmpErase uracil N-glycosylase (UNG) and 1 U of Tac Gold
polymerase. Following the activation of UNG (2 min at 50 °C),
amplification and quantitation [10 min at 95 °C and 40 cycles of
(15 s at 95 °C, 1 min at 60 °C)] were performed with the ABI
7700 sequence detector system (Applied Biosystems). The
principle of real-time PCR has been described elsewhere (Heid
et al., 1996). Standard curves were generated by serial dilution of
known amounts of full-length Ad5p or Ad11p DNA (range 5 to
5 × 105).
FISH
1 × 105 cells were infected with 1 pg/cell of Ad5p, Ad11p or
Ad35 and incubated for 1 h or 3 h. At the end of the incubation
period, the cells were washed and transferred to a microscope
slide (SuperFrost Plus; Menzler Gläser) in 10 μl PBS. After
adherence of the cells to the glass, the cells were fixed in ice-
cold methanol (100%) for 6 min and stored at −20 °C until in
situ hybridization was performed.
Fifteen microliters of hybridization mix containing 1 ng/μl
Ad11p (for detection of Ad11p and Ad35) or 2 ng/μl Ad5p (for
detection of Ad5p), digoxigenin (DIG)-labeled probe, 0.6 μg/μl
salmon sperm DNA, 50% deionized formamide (Fluka), 2.5%
dextran sulfate and 1× SSC was added to each microscope slide
sample, and the slides were covered or sealed with an
incubation chamber (Molecular Probes, Eugene, USA). The
material on the slides was denatured at 80 °C for 5 min, and then
the probes were allowed to hybridize at 37 °C in a moist
chamber overnight. The slides were washed three times for 5
min each in 50% formamide −2× SSC at 42 °C and three times
for 5 min each in 0.1× SSC at 60 °C, with continuous shaking of
the washing vial. The slides were then briefly washed in PBS
and incubated with TNB blocking buffer supplied in the TSA
Fluorescein System kit (see below) for 30 min at RT. The slides
were then incubated with α-DIG-peroxidase (POD)-conjugated
Fab fragments (Roche), diluted 1:100 in TNB blocking buffer,
for 30 min at RT and washed three times for 5 min each in 0.1%PBS–Tween (PBS-T). Thereafter, the slides were incubated
with tyramide signal amplification (TSA) reagent (TSA
Fluorescein System kit; Perkin Elmer, Wellesley, USA), diluted
1:50 in the dilution buffer supplied, for 7 min at RT. The slides
were washed in PBS-T as before and incubated with 0.0025%
Evans Blue in PBS for 5 min at RT. Finally, the slides were
washed three times for 5 min in PBS, briefly rinsed in water and
mounted in antifade mounting medium (DakoCytomation)
before being analyzed using a Leica SP2 confocal imager
system.
Preparation of DIG probes
Probes were made from DNA purified from Ad11p or Ad5p
virions using proteinase K to degrade capsids and the Ad
terminal protein and standard phenol-chloroform extraction
thereafter (Shinagawa et al., 1983). One microgram template
DNA in 16 μl distilled water was mixed with 4 μl of a ready-to-
use mix for Nick-translation (DIG-Nick Translation Mix;
Roche) and incubated at 15 °C for 30 min to 1 h in order to
obtain probes of lengths between 200 bp and 1000 bp labeled
with the DIG epitope. The reaction was stopped by adding 1 μl
0.5 M EDTA (pH 8.0) and subsequent heating to 65 °C for 10
min. The probes were purified using Micro Bio-Spin P-30
columns (Bio-Rad, Hercules, USA), analyzed on an agarose gel
and stored at −20 °C until use.
Immunofluorescent (IF) staining
1 × 105 cells were infected with 3 pg/cell of Ad5p, Ad11p or
Ad35 and incubated for 1 h, 48 h or 96 h. At the end of the
incubation period, the cells were transferred to a SuperFrost
Plus microscope slide (Menzler Gläser), methanol fixed (as
above) and stored at −20 °C until immunofluorescence staining
was performed.
Initially, the slides were blocked with human plasma,
diluted 1:20 in PBS–0.2% HSA, for 30 min at 37 °C.
Thereafter, they were incubated with a mouse α-Ad
monoclonal antibody (cat. no. MAB8052; Labora Chemicon),
recognizing the conserved part of the viral hexon protein,
diluted 1:100 in PBS–0.2% HSA for 1 h at 37 °C. The slides
were then washed 3 × 5 min in PBS and again blocked with
human plasma as described previously. Thereafter, the slides
were incubated with a fluorescein (FITC)-conjugated second-
ary rabbit α-mouse antibody (DakoCytomation), diluted 1:20
in PBS–0.2% HSA, for 30 min at 37 °C. Finally, the slides
were washed as described before, mounted in Fluorescence
Mounting Medium (DakoCytomation) and analyzed using a
Leica DMBR fluorescence microscope. Pictures were taken,
using the same exposure time for all slides, with a Leica DC
(polychrome) camera.
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